Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 16.29
+0.29 (1.81%)
Apr 30, 2026, 3:00 PM CST
SHA:600521 Market Cap
SHA:600521 has a market cap or net worth of 23.84 billion as of April 30, 2026. Its market cap has decreased by -0.16% in one year.
Market Cap
23.84B
Enterprise Value
30.31B
Revenue
8.59B
Ranking
n/a
PE Ratio
88.89
Stock Price
16.29
Market Cap Chart
Since March 4, 2003, SHA:600521's market cap has increased from 3.97B to 23.84B, an increase of 500.48%. That is a compound annual growth rate of 8.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 23.84B | -5.72% |
| Dec 31, 2025 | 25.29B | -2.34% |
| Dec 31, 2024 | 25.89B | 19.93% |
| Dec 29, 2023 | 21.59B | -33.42% |
| Dec 30, 2022 | 32.43B | 0.57% |
| Dec 31, 2021 | 32.25B | -34.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Livzon Pharmaceutical Group | 26.63B |
| Dizal (Jiangsu) Pharmaceutical | 26.14B |
| Hubei Jumpcan Pharmaceutical | 24.63B |
| Kangmei Pharmaceutical | 23.65B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.79B |
| Chengdu Kanghong Pharmaceutical Group | 22.56B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 22.38B |
| Tasly Pharmaceutical Group | 22.38B |